Cosmo Pharmaceuticals NV (OTCPK:CMOPF)
$ 66.9252 0 (0%) Market Cap: 1.14 Bil Enterprise Value: 1.01 Bil PE Ratio: 15.34 PB Ratio: 2.13 GF Score: 84/100

Half Year 2021 Cosmo Pharmaceuticals NV Earnings Call Transcript

Jul 30, 2021 / 12:00PM GMT
Release Date Price: $96
Operator

Ladies and gentlemen, welcome to the release of half year results 2021 conference call and live webcast. I'm Moira, the Chorus Call operator. (Operator Instructions) The conference is being recorded. The presentation will be followed by a Q&A session. (Operator Instructions) The conference must not be recorded for publication or broadcast.

At this time, it's my pleasure to hand over to Alessandro Della Cha, Executive Director and CEO. Please go ahead, sir.

Alessandro E. Della Cha
Cosmo Pharmaceuticals N.V. - CEO & Executive Director

Thank you very much. Welcome, everyone, to our half year report 2021 conference call. I hope the presentation is visible for you all.

Let's start with a quick introduction and a recap on where we stand. Currently, our half year is ending with EUR 28.4 million revenues, EUR 15.2 million of which is related to manufacturing of our own products and related services and EUR 5.8 million to the manufacturing of generic products and other related services. We have cash EUR 2.4 million of royalties and received

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot